Guidance for laboratory biomonitoring programs : developing biomonitoring capabilities
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields



Document Data
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page


Guidance for laboratory biomonitoring programs : developing biomonitoring capabilities

Filetype[PDF-932.79 KB]



  • Alternative Title:
    Guidance for biomonitoring programs
  • Corporate Authors:
  • Description:
    The goals of this guidance are to outline the infrastructure and expertise needed to develop laboratory capacity for a biomonitoring program and to highlight some of the main considerations chemists should address before beginning a biomonitoring study, which include the need to:

    • Define the goals of a biomonitoring study;

    • Choose the appropriate biomarker in the appropriate matrix at a suf cient level of sensitivity;

    • Identify resource needs and sources of potential funding;

    • Collaborate with epidemiologists and toxicologists in the development of the study design and to analyze and communicate biomonitoring data;

    • Produce reliable, valid and comparable data;

    • Engage the community early in the study design process; and

    • Develop an effective communication plan that involves reporting of individual results (if appropriate), aggregate data and access to public health, citizens or medical professionals for results distribution and interpretation.

    While the technology and instrumentation used for biomonitoring testing have a lot in common with environmental testing laboratories, biomonitoring presents a set of unique challenges. Assaying clinical matrices involves the safe handling of potentially infectious materials, different interferences, and possibly the analysis of metabolites. The greatest differences between bio- monitoring and environmental testing involve the interpretation of clinical ndings and effective communication of results on an individual and community basis.


    Running title: Guidance for biomonitoring programs.

    This report was supported 100% by Cooperative Agreement Number #U60/CD303019 from Centers for Disease Con- trol and Prevention (“CDC”). Its contents are solely the responsibility of the authors and do not necessarily represent the of cial views of CDC.

  • Subjects:
  • Series:
  • Document Type:
  • Funding:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at